首页 / 院系成果 / 成果详情页

Distinctly altered gut microbiota in the progression of liver disease 期刊论文

编号：

c3797257-7b88-4372-bf0c-c0f3d75823df
作者：

Xie, Guoxiang#^[1,2,3]Wang, Xiaoning(王晓柠)^[4,5]Liu, Ping(刘平)^[4,5]Wei, Runmin^[3];Chen, Wenlian^[3];Rajani, Cynthia^[3];Hernandez, Brenda Y.^[3];Alegado, Rosanna^[6];Dong, Bing^[7];Li, Defa^[7];Jia, Wei*^[1,2,3,4]
语种：

英文
期刊：

ONCOTARGET ISSN：1949-2553 2016 年 7 卷 15 期 (19355 - 19366) ; APR 12
收录：
关键词：

gut microbiota lipopolysaccharides liver disease pathogenesis Immunology and Microbiology Section Immune response Immunity
摘要：

Recent studies underscore important roles of intestinal microbiota and the bacterial lipopolysaccharides (LPS) production in the pathogenesis of liver disease. However, how gut microbiota alters in response to the development of steatosis and subsequent progression to nonalcoholic steatohepatitis (NASH) and hepatocellular carcinoma (HCC) remains unclear. We aimed to study the gut microbial changes over liver disease progression using a streptozotocin-high fat diet (STZ-HFD) induced NASH-HCC C57BL/6J mouse model that is highly relevant to human liver disease. The fecal microbiota at various liver pathological stages was analyzed by 16S rDNA gene pyrosequencing. Both UniFrac analysis and partial least squares-discriminant analysis showed significant structural alterations in gut microbiota during the development of liver disease. Co-abundance network analysis highlighted relationships between genera. Spearman correlation analysis revealed that the bacterial species, Atopobium spp., Bacteroides spp., Bacteroides vulgatus, Bacteroides acidifaciens, Bacteroides uniformis, Clostridium cocleatum, Clostridium xylanolyticum and Desulfovibrio spp., markedly increased in model mice, were positively correlated with LPS levels and pathophysiological features. Taken together, the results showed that the gut microbiota was altered significantly in the progression of liver disease. The connection between the gut microbial ecology and the liver pathology may represent potential targets for the prevention and treatment of chronic liver disease and HCC.
推荐引用方式
GB/T 7714：

Xie Guoxiang,Wang Xiaoning,Liu Ping, et al. Distinctly altered gut microbiota in the progression of liver disease [J].ONCOTARGET,2016,7(15):19355-19366.
APA：

Xie Guoxiang,Wang Xiaoning,Liu Ping,Wei Runmin,&Jia Wei.(2016).Distinctly altered gut microbiota in the progression of liver disease .ONCOTARGET,7(15):19355-19366.
MLA：

Xie Guoxiang, et al. "Distinctly altered gut microbiota in the progression of liver disease" .ONCOTARGET 7,15(2016):19355-19366.
条目包含文件：

文件类型：PDF,文件大小：

正在加载全文

未找到全文

浏览次数：514  下载次数：0

分享到：

浏览次数：514

下载次数：0

打印次数：0